newsfilter
← Latest News
Business Wire·

Concert Pharmaceuticals Reports Second Quarter 2021 Financial Results

CTP-543 Phase 3 Program On Track to Support NDA Filing in Early 2023 Conference Call Scheduled Today at 8:30 a.m. ET Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) today reported financial results for the second quarter of 2021. "Our development p